Health Condition 1: N33- Bladder disorders in diseases classified elsewhere
Conditions
Interventions
Intervention1: Lignocaine jelly instillation in posterior urethra and in anterior urethra before cystoscopy: After explaining the procedure and obtaining informed consent, the patient shall be positio
Sponsors
CMC Fluid research funding
Eligibility
Inclusion criteria
Inclusion criteria: Adult males between 18-75 years where diagnostic cystoscopy is indicated
Exclusion criteria
Exclusion criteria: 1.Age less than 18 years or more than 75 years. 2.Oral/injectable analgesic usage in last 24 hours. 3.Known or diagnosed urethral stricture. 4.Meatal or submeatal stenosis requiring dilation. 5.Need for additional procedure like stent removal, fulguration or biopsy. 6.Known allergy/intolerance to lignocaine jelly. 7.Patient who cannot be positioned into lithotomy due to musculoskeletal diseases. 8.Neurological disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score (patient reported) by Visual analog scale (0-10)Timepoint: 1.Following the application of the penile clamp, 2.At the end of cystoscopy, and 3.At 2 hours after cystoscopy (after voiding). | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of procedure (in minutes)Timepoint: At the end of cystoscopy;Surgeonâ??s assessment of patient comfort/compliance during the cystoscopy. (0-10) Timepoint: At the end of cystoscopy | — |
Countries
India
Contacts
Public ContactAbhik Debnath
CMC Vellore
Outcome results
None listed